{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T06:40:30Z","timestamp":1785825630395,"version":"3.56.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2015,5,3]],"date-time":"2015-05-03T00:00:00Z","timestamp":1430611200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2015,5,3]],"date-time":"2015-05-03T00:00:00Z","timestamp":1430611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Microbiol Biotechnol"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s00253-015-6602-5","type":"journal-article","created":{"date-parts":[[2015,5,2]],"date-time":"2015-05-02T04:03:44Z","timestamp":1430539424000},"page":"4845-4853","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["A monoclonal antibody-based VZV glycoprotein E quantitative assay and its application on antigen quantitation in VZV vaccine"],"prefix":"10.1007","volume":"99","author":[{"given":"Jian","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangzhong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianwei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongmei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianghui","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinjian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningshao","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,5,3]]},"reference":[{"issue":"4","key":"6602_CR1","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/S1369-5274(00)00233-2","volume":"4","author":"AM Arvin","year":"2001","unstructured":"Arvin AM (2001) Varicella-zoster virus: molecular virology and virus-host interactions. Curr Opin Microbiol 4(4):442\u20139","journal-title":"Curr Opin Microbiol"},{"issue":"2","key":"6602_CR2","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0166-0934(03)00129-0","volume":"110","author":"HG Bae","year":"2003","unstructured":"Bae HG, Nitsche A, Teichmann A, Biel SS, Niedrig M (2003) Detection of yellow fever virus: a comparison of quantitative real-time PCR and plaque assay. J Virol Methods 110(2):185\u201391","journal-title":"J Virol Methods"},{"issue":"1","key":"6602_CR3","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1128\/JVI.00913-08","volume":"83","author":"B Berarducci","year":"2009","unstructured":"Berarducci B, Rajamani J, Reichelt M, Sommer M, Zerboni L, Arvin AM (2009) Deletion of the first cysteine-rich region of the varicella-zoster virus glycoprotein E ectodomain abolishes the gE and gI interaction and differentially affects cell-cell spread and viral entry. J Virol 83(1):228\u201340. doi:10.1128\/JVI.00913-08","journal-title":"J Virol"},{"issue":"12","key":"6602_CR4","doi-asserted-by":"publisher","first-page":"5825","DOI":"10.1128\/JVI.00303-08","volume":"82","author":"X Che","year":"2008","unstructured":"Che X, Reichelt M, Sommer MH, Rajamani J, Zerboni L, Arvin AM (2008) Functions of the ORF9-to-ORF12 gene cluster in varicella-zoster virus replication and in the pathogenesis of skin infection. J Virol 82(12):5825\u201334. doi:10.1128\/JVI.00303-08","journal-title":"J Virol"},{"key":"6602_CR5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jviromet.2014.01.014","volume":"200C","author":"L Chen","year":"2014","unstructured":"Chen L, Liu J, Wang W, Ye J, Wen L, Zhao Q, Zhu H, Cheng T, Xia N (2014) Development of a varicella-zoster virus neutralization assay using a glycoprotein K antibody enzyme-linked immunosorbent spot assay. J Virol Methods 200C:10\u201314. doi:10.1016\/j.jviromet.2014.01.014","journal-title":"J Virol Methods"},{"issue":"20","key":"6602_CR6","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1016\/j.vaccine.2012.01.088","volume":"30","author":"N Dendouga","year":"2012","unstructured":"Dendouga N, Fochesato M, Lockman L, Mossman S, Giannini SL (2012) Cell-mediated immune responses to a varicella-zoster virus glycoprotein E vaccine using both a TLR agonist and QS21 in mice. Vaccine 30(20):3126\u201335. doi:10.1016\/j.vaccine.2012.01.088","journal-title":"Vaccine"},{"issue":"16","key":"6602_CR7","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1503\/cmaj.091711","volume":"182","author":"M Drolet","year":"2010","unstructured":"Drolet M, Brisson M, Schmader KE, Levin MJ, Johnson R, Oxman MN, Patrick D, Blanchette C, Mansi JA (2010) The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study. CMAJ : Can Med Assoc J = journal de l'Association medicale canadienne 182(16):1731\u20136. doi:10.1503\/cmaj.091711","journal-title":"CMAJ : Can Med Assoc J = journal de l'Association medicale canadienne"},{"issue":"8","key":"6602_CR8","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1073\/pnas.38.8.747","volume":"38","author":"R Dulbecco","year":"1952","unstructured":"Dulbecco R (1952) Production of plaques in monolayer tissue cultures by single particles of an animal virus. Proc Natl Acad Sci U S A 38(8):747\u201352","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"6602_CR9","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1007\/BF02176199","volume":"8","author":"R Dulbecco","year":"1952","unstructured":"Dulbecco R, Weigle JJ (1952) Inhibition of bacteriophage development in bacteria illumination with visible light. Experientia 8(10):386\u20137","journal-title":"Experientia"},{"key":"6602_CR10","unstructured":"GlaxoSmithKline (2014) Pivotal phase III study of GSK shingles candidate vaccine meets its primary endpoint. Publisher. http:\/\/www.gsk.com\/en-gb\/media\/press-releases\/2014\/pivotal-phase-iii-study-of-gsk-shingles-candidate-vaccine-meets-its-primary-endpoint\/ Accessed 19 February 2015"},{"issue":"Suppl 2","key":"6602_CR11","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1086\/522156","volume":"197","author":"D Guris","year":"2008","unstructured":"Guris D, Jumaan AO, Mascola L, Watson BM, Zhang JX, Chaves SS, Gargiullo P, Perella D, Civen R, Seward JF (2008) Changing varicella epidemiology in active surveillance sites\u2014United States, 1995\u20132005. J Infect Dis 197(Suppl 2):S71\u20135. doi:10.1086\/522156","journal-title":"J Infect Dis"},{"issue":"1","key":"6602_CR12","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0166-0934(98)00176-1","volume":"79","author":"K Hawrami","year":"1999","unstructured":"Hawrami K, Breuer J (1999) Development of a fluorogenic polymerase chain reaction assay (TaqMan) for the detection and quantitation of varicella zoster virus. J Virol Methods 79(1):33\u201340","journal-title":"J Virol Methods"},{"issue":"2","key":"6602_CR13","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1006\/viro.1997.8625","volume":"233","author":"H Kimura","year":"1997","unstructured":"Kimura H, Straus SE, Williams RK (1997) Varicella-zoster virus glycoproteins E and I expressed in insect cells form a heterodimer that requires the N-terminal domain of glycoprotein I. Virology 233(2):382\u201391. doi:10.1006\/viro.1997.8625","journal-title":"Virology"},{"issue":"Suppl 1","key":"6602_CR14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1086\/514256","volume":"178","author":"H Kimura","year":"1998","unstructured":"Kimura H, Straus SE, Williams RK (1998) Baculovirus expression, purification, and properties of varicella-zoster virus gE, gI, and the complex they form. J Infect Dis 178(Suppl 1):13\u201315","journal-title":"J Infect Dis"},{"issue":"3","key":"6602_CR15","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/0166-0934(90)90100-T","volume":"27","author":"DL Krah","year":"1990","unstructured":"Krah DL, Schofield TL, Provost PJ (1990) Enhancement of varicella-zoster virus plaquing efficiency with an agarose overlay medium. J Virol Methods 27(3):319\u201325","journal-title":"J Virol Methods"},{"issue":"7","key":"6602_CR16","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.4161\/hv.24269","volume":"9","author":"H Lal","year":"2013","unstructured":"Lal H, Zahaf T, Heineman TC (2013) Safety and immunogenicity of an AS01-adjuvanted varicella zoster virus subunit candidate vaccine (HZ\/su): a phase-I, open-label study in Japanese adults. Hum Vaccin Immunother 9(7):1425\u20139. doi:10.4161\/hv.24269","journal-title":"Hum Vaccin Immunother"},{"key":"6602_CR17","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00407-13","author":"T Lenac Rovis","year":"2013","unstructured":"Lenac Rovis T, Bailer SM, Pothineni VR, Ouwendijk WJ, Simic H, Babic M, Miklic K, Malic S, Verweij MC, Baiker A, Gonzalez O, von Brunn A, Zimmer R, Fruh K, Verjans GM, Jonjic S, Haas J (2013) A comprehensive analysis of varicella zoster virus proteins using a new monoclonal antibody collection. J Virol. doi:10.1128\/JVI.00407-13","journal-title":"J Virol"},{"issue":"8","key":"6602_CR18","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1093\/infdis\/jis497","volume":"206","author":"I Leroux-Roels","year":"2012","unstructured":"Leroux-Roels I, Leroux-Roels G, Clement F, Vandepapeliere P, Vassilev V, Ledent E, Heineman TC (2012) A phase 1\/2 clinical trial evaluating safety and immunogenicity of a varicella zoster glycoprotein e subunit vaccine candidate in young and older adults. J Infect Dis 206(8):1280\u201390. doi:10.1093\/infdis\/jis497","journal-title":"J Infect Dis"},{"issue":"1","key":"6602_CR19","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1128\/CVI.05388-11","volume":"19","author":"L Liu","year":"2012","unstructured":"Liu L, Wen K, Li J, Hu D, Huang Y, Qiu L, Cai J, Che X (2012) Comparison of plaque- and enzyme-linked immunospot-based assays to measure the neutralizing activities of monoclonal antibodies specific to domain III of dengue virus envelope protein. Clin Vaccine Immunol 19(1):73\u20138. doi:10.1128\/CVI.05388-11","journal-title":"Clin Vaccine Immunol"},{"issue":"22","key":"6602_CR20","doi-asserted-by":"publisher","first-page":"12406","DOI":"10.1128\/JVI.78.22.12406-12415.2004","volume":"78","author":"J Moffat","year":"2004","unstructured":"Moffat J, Mo C, Cheng JJ, Sommer M, Zerboni L, Stamatis S, Arvin AM (2004) Functions of the C-terminal domain of varicella-zoster virus glycoprotein E in viral replication in vitro and skin and T-cell tropism in vivo. J Virol 78(22):12406\u201315. doi:10.1128\/JVI.78.22.12406-12415.2004","journal-title":"J Virol"},{"key":"6602_CR21","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit344","author":"KM Mullane","year":"2013","unstructured":"Mullane KM, Winston DJ, Wertheim MS, Betts RF, Poretz DM, Camacho LH, Pergam SA, Mullane MR, Stek JE, Sterling TM, Zhao Y, Manoff SB, Annunziato PW (2013) Safety and immunogenicity of heat-treated zoster vaccine (ZVHT) in immunocompromised adults. J Infect Dis. doi:10.1093\/infdis\/jit344","journal-title":"J Infect Dis"},{"issue":"5","key":"6602_CR22","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1056\/NEJMoa042271","volume":"352","author":"HQ Nguyen","year":"2005","unstructured":"Nguyen HQ, Jumaan AO, Seward JF (2005) Decline in mortality due to varicella after implementation of varicella vaccination in the United States. N Engl J Med 352(5):450\u20138. doi:10.1056\/NEJMoa042271","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"6602_CR23","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1086\/514255","volume":"178","author":"JK Olson","year":"1998","unstructured":"Olson JK, Santos RA, Grose C (1998) Varicella-zoster virus glycoprotein gE: endocytosis and trafficking of the Fc receptor. J Infect Dis 178(Suppl 1):S2\u20136","journal-title":"J Infect Dis"},{"issue":"22","key":"6602_CR24","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1056\/NEJMoa051016","volume":"352","author":"MN Oxman","year":"2005","unstructured":"Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Arbeit RD, Simberkoff MS, Gershon AA, Davis LE, Weinberg A, Boardman KD, Williams HM, Zhang JH, Peduzzi PN, Beisel CE, Morrison VA, Guatelli JC, Brooks PA, Kauffman CA, Pachucki CT, Neuzil KM, Betts RF, Wright PF, Griffin MR, Brunell P, Soto NE, Marques AR, Keay SK, Goodman RP, Cotton DJ, Gnann JW Jr, Loutit J, Holodniy M, Keitel WA, Crawford GE, Yeh SS, Lobo Z, Toney JF, Greenberg RN, Keller PM, Harbecke R, Hayward AR, Irwin MR, Kyriakides TC, Chan CY, Chan IS, Wang WW, Annunziato PW, Silber JL (2005) A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 352(22):2271\u201384. doi:10.1056\/NEJMoa051016","journal-title":"N Engl J Med"},{"issue":"4","key":"6602_CR25","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/rmv.502","volume":"16","author":"M Quinlivan","year":"2006","unstructured":"Quinlivan M, Breuer J (2006) Molecular studies of varicella zoster virus. Rev Med Virol 16(4):225\u201350. doi:10.1002\/rmv.502","journal-title":"Rev Med Virol"},{"key":"6602_CR26","doi-asserted-by":"crossref","unstructured":"Schmid DS (2010) Varicella-zoster virus vaccine: molecular genetics. In: Abendroth A, Arvin AM, Moffat JF (eds). Springer, pp 323-340","DOI":"10.1007\/82_2010_14"},{"key":"6602_CR27","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00128-12","author":"A Selariu","year":"2012","unstructured":"Selariu A, Cheng T, Tang Q, Silver B, Yang L, Liu C, Ye X, Markus A, Goldstein RS, Cruz Cosme RS, Lin Y, Wen L, Qian H, Han J, Dulal K, Huang Y, Li Y, Xia N, Zhu H (2012) ORF7 of varicella zoster virus is a neurotropic factor. J Virol. doi:10.1128\/JVI.00128-12","journal-title":"J Virol"},{"issue":"5","key":"6602_CR28","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1001\/jama.287.5.606","volume":"287","author":"JF Seward","year":"2002","unstructured":"Seward JF, Watson BM, Peterson CL, Mascola L, Pelosi JW, Zhang JX, Maupin TJ, Goldman GS, Tabony LJ, Brodovicz KG, Jumaan AO, Wharton M (2002) Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. JAMA : J Am Med Assoc 287(5):606\u201311","journal-title":"JAMA : J Am Med Assoc"},{"issue":"35","key":"6602_CR29","doi-asserted-by":"publisher","first-page":"14086","DOI":"10.1073\/pnas.0706023104","volume":"104","author":"L Zerboni","year":"2007","unstructured":"Zerboni L, Reichelt M, Jones CD, Zehnder JL, Ito H, Arvin AM (2007) Aberrant infection and persistence of varicella-zoster virus in human dorsal root ganglia in vivo in the absence of glycoprotein I. Proc Natl Acad Sci U S A 104(35):14086\u201391. doi:10.1073\/pnas.0706023104","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"17","key":"6602_CR30","doi-asserted-by":"publisher","first-page":"9024","DOI":"10.1128\/JVI.02666-06","volume":"81","author":"Z Zhang","year":"2007","unstructured":"Zhang Z, Rowe J, Wang W, Sommer M, Arvin A, Moffat J, Zhu H (2007) Genetic analysis of varicella-zoster virus ORF0 to ORF4 by use of a novel luciferase bacterial artificial chromosome system. J Virol 81(17):9024\u201333. doi:10.1128\/JVI.02666-06","journal-title":"J Virol"},{"key":"6602_CR31","doi-asserted-by":"publisher","first-page":"e1000971","DOI":"10.1371\/journal.ppat.1000971","volume":"6","author":"Z Zhang","year":"2010","unstructured":"Zhang Z, Selariu A, Warden C, Huang G, Huang Y, Zaccheus O, Cheng T, Xia N, Zhu H (2010) Genome-wide mutagenesis reveals that ORF7 is a novel VZV skin-tropic factor. PLoS Pathog 6:e1000971. doi:10.1371\/journal.ppat.1000971","journal-title":"PLoS Pathog"},{"issue":"7","key":"6602_CR32","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1001\/jama.294.7.797","volume":"294","author":"F Zhou","year":"2005","unstructured":"Zhou F, Harpaz R, Jumaan AO, Winston CA, Shefer A (2005) Impact of varicella vaccination on health care utilization. JAMA : J Am Med Assoc 294(7):797\u2013802. doi:10.1001\/jama.294.7.797","journal-title":"JAMA : J Am Med Assoc"}],"container-title":["Applied Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-015-6602-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00253-015-6602-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-015-6602-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-015-6602-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T04:40:37Z","timestamp":1744173637000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00253-015-6602-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,3]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["6602"],"URL":"https:\/\/doi.org\/10.1007\/s00253-015-6602-5","relation":{},"ISSN":["0175-7598","1432-0614"],"issn-type":[{"value":"0175-7598","type":"print"},{"value":"1432-0614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,3]]},"assertion":[{"value":"11 December 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}